SlideShare a Scribd company logo
Clinical significance of
diminished ovarian reserve
Richard A Anderson
Elsie Inglis Professor of Clinical Reproductive Science
University of Edinburgh
The ‘poor responder’
• What do we mean by this term?
• Is it reliable?
• What can we do about it?
• What might we be able to do about it?
Association between egg number
and live birth rate
Sunkara SK et al. Hum. Reprod. 2011;26:1768-1774
HFEA data: 400,000 cycles
The increasing gap between
women’s wishes and biology
0
5
10
15
20
25
<29 30-34 35-39 40-44 >45
Live birth
rate per ET
Templeton et al 1996 Lancet 384; 1402
0
50000
100000
150000
200000
250000
300000
<20 20-24 25-29 30-34 35-39 40-44 45+
1995
2005
OHE Compendium of Health Statistics
The variation as well as decline in
follicular endowment
Wallace and Kelsey 2010 PLoS One 5; e8772
Non-growing
follicle
number
Age
Wallace and Kelsey 2010 PLoS One 5; e8772
200/month
6.7 per day
22/month 2000/month
Calculation of
rate of follicle
activation
The long and hazardous road of follicle
development
From McGee and Hsueh 2000 Endocr Rev 21, 200
??? 120 Days
Primordial
Primary
Secondary
Antral
Human
(2 - 5mm)
Rat
(0.2 - 0.4mm)
Atretic
Pre-ovulatory
Follicles
OVULATION
SELECTION AND
DOMINANCE
CYCLIC
RECRUITMENT
INITIAL
RECRUITMENT
>30 Days 28 Days 2-3 Days
71 Days 14 Days
Human
Rat
Similar durations in Gougeon A 1986 Hum Reprod
On the radar
AMH and AFC reflect
primordial follicle number
Hansen et al 2010 Fertil Steril
Stereological analysis
following
oophorectomy, n=42
LogPrimordialfolliclenumber
R² = 0.6646
0
1
2
3
4
5
6
7
0 1 2 3 4 5 6
AMH(ng/ml)
Log NGF number
NGF vs AMH
R² = 0.600
1
10
100
20 30 40 50 60NGF/AMH
Age
NGF/AMH ratio vs age
Fewer antral follicles per NGF with age
Increased early selection?
The changing relationship between primordial
follicle number and AMH with age
Prediction of poor response
AUROC 95% CI
Age 0.60 0.57, 0.64
AMH 0.81 0.77, 0.84
Age, FSH 0.69 0.66, 0.72
Age, AFC 0.76 0.72, 0.80
Age, AMH 0.80 0.76, 0.84
Age, AMH, AFC 0.80 0.74, 0.86
Age, AMH, AFC, FSH 0.81 0.75, 0.0.86
IMPORT consortium Hum Repro Update 2013
EXPORT consortium Fertil Steril 2013
Biomarkers predict poor response
‘Bologna’ criteria for poor response
• 2 of 3:
– Advanced maternal age or other risk factor
– Previous POR (≤3 oocytes)
– Abnormal ovarian reserve test
• Or 2 episodes of POR with max stimulation
• Reproducibility in a second cycle:
– 64% of ‘unexpected’ will show a normal response
– 31% of ‘expected’ will show a normal response
(n=225, Klinkert et al 2004)
Ferraretti AP et al; ESHRE working group on Poor Ovarian Response Definition 2011
69% of DOR cycles did
not result in POR
0
5
10
15
20
2004 2011
DOR live birth
POR live birth
Devine K et al Fertil Steril 2015, 3, 612
Using ‘Diminished ovarian reserve’ to predict
poor ovarian response
Diminished ovarian reserve in the United States assisted reproductive technology
population: diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive
Technology Clinic Outcomes Reporting System
Chai J, Lee VCY, Yeung TWY, Li RWH, Ho PC, et al. (2015) Live Birth and Cumulative Live Birth Rates in Expected Poor Ovarian Responders
Defined by the Bologna Criteria Following IVF/ICSI Treatment. PLoS ONE 10(3): e0119149.
Expected Normal (562) Expected Poor (160)
No of oocytes 11 (8-15) 5 (3-8)
Cancellations 0 1 (0.6%)
Live birth 202 (35.9%) 38 (23.8%)
Fresh plus frozen LBR 323/512 (62.8%) 48/134 (35.8%)
How well do predicted poor
responders do in IVF/ICSI?
1152 women undergoing first IVF/ICSI cycle (cutoffs: age 40, AFC 6, AMH 2ng/ml)
SART data by diagnosis
Luke et al 2012 NEJM 366, 2483
ROC analysis for AMH and successful egg retrieval in DOR patients (FSH>10IU/L)
Burks HR et al Fertil Sertil 2015, 3, 643
Can we do better?
Ultrasensitive AMH assay
No egg retrievals at <100pg/ml
n=24 /group
What else does having a poor ovarian
reserve mean?
From McGee and Hsueh 2000 Endocr Rev 21, 200
??? 120 Days
Primordial
Primary
Secondary
Antral
Human
(2 - 5mm)
Rat
(0.2 - 0.4mm)
Atretic
Pre-ovulatory
Follicles
OVULATION
SELECTION AND
DOMINANCE
CYCLIC
RECRUITMENT
INITIAL
RECRUITMENT
>30 Days 28 Days 2-3 Days
71 Days 14 Days
Human
Rat
Sowers, M. R. et al. J Clin Endocrinol Metab 2008;93:3478-3483
Prediction of menopause
50 women followed prospectively
(Michigan Bone Health and
Metabolism Study)
6 annual assessments
Mean initial age 42 yr
AMH signif related to both time to and
age at FMP
Inhibin B less predictive of both
AMH and prediction of menopause
Broer SL et al 2011 JCE&M
257 ovulatory women, 21-46yr
Reassessed after 11 years (19% menopausal)
AMH at baseline Menopause by AMH centileLow age specific AMH
Shift towards younger
age at menopause
High age specific
AMH
Shift towards higher
age at menopause
AMH and prediction of menopause
Tehrani et al 2013 JCE&M 98, 729
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0 1 2 3 4 5 6
Cumulativeproportionofwomen
achievingpregnancy
Time from cessation of birth control
(cycles)
0
10
20
30
40
50
60
70
19 21 23 25 27 29 31 33 35
AMH(pmol/L)
Age (years)
AMH and fecundability
Hagen et al 2012 Fertil Steril
AMH quintiles, middle 3 combined
981 women aged 30 to 44, trying to conceived max 3 months at study entry Steiner AZ et al, 2017, JAMA
Adjusted for age,
smoking,
contraception, BMI,
race, prev
pregnancy
Changes in ovarian reserve after
chemotherapy
Identification of post-
cancer compromised
ovarian reserve?
Ovarianreserve
Effects of A(B)VD and BEACOPP on
ovarian function in Hodgkin lymphoma
0
5
10
15
20
Pre chemo 2 cycles EOT 1 2 3
AMH(pmol/L) AMH
Blue: ABVD
Red: BEACOPP
(after 2 cycles of ABVD)
Years after chemotherapy
Chemotherapy
Anderson RA et al 2018 Lancet Oncol
AMH and pregnancy after HL
0
2
4
6
8
10
12
Pre chemo 2 cycles EOT 1 2 3
AMH(pmol/l)
During pregnancy
Pre
C
ycle
1
C
ycle
2
C
ycle
3
C
ycle
4
C
ycle
5
C
ycle
6
0.0
0.5
1.0
1.5
2.0
2.5
**
**
*** ***
AMH(ng/ml)
AMH: application in childhood
cancer
Pre End Recovery
0
1
2
3
* **
AMH(ng/ml)
High risk
Pre End Recovery
0
1
2
3
**
AMH(ng/ml)
Medium/low risk
22 girls age 0.3-15yr
17 prepubertal
Brougham et al 2012 JCE&M 97, 2059
AMH in 3 girls with cancer
0 50 100 150 200
0.0
1.0
2.0
3.0
Age 2.4; rhabdomyosarcoma
0 25 50 75
0.0
0.2
0.4
0.6
0.8
1.0
Weeks
AMH(ng/ml)
Age 1.2; neuroblastoma
0 50 100 150
0.0
0.5
1.0
1.5
2.0
Weeks
Age 14.6: Hodgkin’s lymphoma
Brougham et al 2012 JCE&M 97, 2059
Can this predict their
reproductive lifespan?
Age and miscarriage
Maternal age
Percentmiscarrying
Nyboe Andersen et al 2000 BMJ 320, 1708
AMH and miscarriage after IVF?
Tarasconi et al Fertil Steril 2017, 108, 518
Age but not AMH predicted clinical pregnancy and live birth
AMH and miscarriage in natural
pregnancy?
Schumacker et al 2018 Fertil Steril 109, 1065Women (n = 533), age 30 - 44
Women with severely
diminished ovarian reserve (AMH < 0.4 ng/mL)
miscarried at over twice the rate of women
with an AMH > 1 ng/mL (HR 2.3; 1.3-4.3).
AMH and miscarriage in natural
pregnancy?
multivariable Cox model adjusting for
maternal age, race, obesity, and recurrent
pregnancy loss suggested that risk of
miscarriage showed a nonsignificant
trend to decrease with increasing AMH
(HR per unit increase in natural log of
AMH = 0.85; 0.72-1.01).
Schumacker et al 2018 Fertil Steril 109, 1065
Can we intervene to promote follicle
development?
From McGee and Hsueh 2000 Endocr Rev 21, 200
??? 120 Days
Primordial
Primary
Secondary
Antral
Human
(2 - 5mm)
Rat
(0.2 - 0.4mm)
Atretic
Pre-ovulatory
Follicles
OVULATION
SELECTION AND
DOMINANCE
CYCLIC
RECRUITMENT
INITIAL
RECRUITMENT
>30 Days 28 Days 2-3 Days
71 Days 14 Days
Human
Rat
Local and gonadotrophic regulation of
follicle growth
Scaramuzzi R et al 1993 Reprod Fertil Develop 5: 459-478
Local
FSH
Does giving more FSH help?
N=501 Standard 150 IU 225 or 450 IU
Oocytes retrieved 6.5 7.6
Cancelled first cycle 21% 7%
LBR first cycle 18% 18%
Cumulative LBR 44.8% 42.4%
van Tilborg et al 2017 Hum Reprod 32, 2496
OPTIMIST trial: predicted poor responders (AFC ≤7, 8-10)
Outcome: ongoing pregnancy/LB within 18 months
RECOMMENDATIONS
In patients who are classified as poor responders and pursuing
IVF, strong consideration should be given to a mild ovarian-
stimulation protocol (low-dose gonadotropins [≤150IU/d] with or
without oral agents) due to lower costs and comparable low
pregnancy rates compared with traditional IVF stimulation protocols.
Adding growth hormone?
N=130 rGH +FSH FSH only
LBR 11% 14%
Hart RJ et al Curr Opin Obstet Gynecol 2017
LIGHT study
rGH group had more egg recoveries and 1 day less ovarian stimulation
Recruitment stopped early
a benefit for the use of the adjunct GH, with a reduction in the duration of ovarian
stimulation required for oocyte retrieval, the collection of a greater number of oocytes
than placebo, and an improvement in many of the early clinical parameters; however,
there was no evidence of an increased chance of a live birth for the use of GH
Local and gonadotrophic regulation of
follicle growth
Scaramuzzi R et al 1993 Reprod Fertil Develop 5: 459-478
Local
Gns
By size
Vendola KA et al 1998 J Clin Invest 12, 2622
Androgens stimulate early follicular
growth in the primate
Rhesus monkey
Treated with T or DHT
DHEA pretreatment and LBR/ongoing
pregnancy
Nagels HE et al Cochrane Database Syst Rev. 2015:CD009749
OR 1.81, 95% CI 1.25 to 2.62
(8 RCTs, N = 878)
Testosterone pretreatment and LBR/ongoing
pregnancy
Nagels HE et al Cochrane Database Syst Rev. 2015:CD009749
OR 2.60, 95% CI 1.30 to 5.20
(four RCTs, N = 345)
Novel loci to impact follicle development
From McGee and Hsueh 2000 Endocr Rev 21, 200
??? 120 Days
Primordial
Primary
Secondary
Antral
Human
(2 - 5mm)
Rat
(0.2 - 0.4mm)
Atretic
Pre-ovulatory
Follicles
OVULATION
SELECTION AND
DOMINANCE
CYCLIC
RECRUITMENT
INITIAL
RECRUITMENT
>30 Days 28 Days 2-3 Days
71 Days 14 Days
Human
Rat
AMH
Regulation of
growth activation
 sensitivity to
FSH/selection
Campbell BK et al. Endocrinology 2012;153:4533-4543
Immunisation against AMH
promotes follicle progression
in sheep
Intraovarian AMH antibody increases the number of
antral follicles at midcycle
and primates
Xu J et al. Hum. Reprod. 2016;31:1522-1530
Control +AMH antibody
Conclusions
• Diminished ovarian reserve is common but we
aren’t very good at predicting poor response
• But still has acceptable outcomes in younger
women
• Can we improve response and outcomes?
– Yes, but effect size and safety/risks unclear
– Improved understanding of ovarian function
will allow new developments

More Related Content

What's hot

Anti mullerian hormone
Anti mullerian hormoneAnti mullerian hormone
Anti mullerian hormone
Deepak Sanghavi
 
Poor ovarian Response
Poor ovarian ResponsePoor ovarian Response
Poor ovarian ResponseManal Kamel
 
Management of poor ovarian reserve- Dr Parul Katiyar
Management of poor ovarian reserve- Dr Parul KatiyarManagement of poor ovarian reserve- Dr Parul Katiyar
Management of poor ovarian reserve- Dr Parul Katiyar
Dr Parul Katiyar
 
Role Of AMH In Infertility , Dr. Sharda Jain , Life Care Centre
Role Of AMH In Infertility , Dr. Sharda Jain , Life Care Centre Role Of AMH In Infertility , Dr. Sharda Jain , Life Care Centre
Role Of AMH In Infertility , Dr. Sharda Jain , Life Care Centre
Lifecare Centre
 
LETROZOLE IN THE MANAGEMENT OF INFERTILITY
 LETROZOLE IN THE MANAGEMENT OF INFERTILITY LETROZOLE IN THE MANAGEMENT OF INFERTILITY
LETROZOLE IN THE MANAGEMENT OF INFERTILITY
G A RAMA Raju
 
Reduced ovarian reserve aveya
Reduced ovarian reserve aveyaReduced ovarian reserve aveya
Reduced ovarian reserve aveya
Archana Tandon
 
OVARIAN RESERVE AND INFERTILITY
OVARIAN RESERVE AND INFERTILITYOVARIAN RESERVE AND INFERTILITY
OVARIAN RESERVE AND INFERTILITY
drangelosmith
 
Letrozole in Ovulation Induction
Letrozole in Ovulation InductionLetrozole in Ovulation Induction
Letrozole in Ovulation Induction
Sujoy Dasgupta
 
Ovarian Reserve Testing in Infertility Dr. Jyoti Agarwal Dr. Sharda Jain
Ovarian  Reserve Testing in Infertility Dr. Jyoti Agarwal Dr. Sharda JainOvarian  Reserve Testing in Infertility Dr. Jyoti Agarwal Dr. Sharda Jain
Ovarian Reserve Testing in Infertility Dr. Jyoti Agarwal Dr. Sharda Jain
Lifecare Centre
 
Management of poor ovarian response
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian responseHesham Gaber
 
Assessment and treatment of people with fertility problem NICE guideline, 2013
Assessment and treatment of people with fertility problemNICE guideline, 2013Assessment and treatment of people with fertility problemNICE guideline, 2013
Assessment and treatment of people with fertility problem NICE guideline, 2013
Aboubakr Elnashar
 
Amh test
Amh testAmh test
Amh
AmhAmh
Discordance between AMH &FSH
Discordance between AMH &FSHDiscordance between AMH &FSH
Discordance between AMH &FSH
Aboubakr Elnashar
 
Ovulation Induction in PCOS
Ovulation Induction in PCOSOvulation Induction in PCOS
Ovulation Induction in PCOS
Al Mamun
 
Ovarian Stimulation in IUI- Overview Sr. Jyoti Bhaskar
Ovarian Stimulation in IUI- Overview Sr. Jyoti BhaskarOvarian Stimulation in IUI- Overview Sr. Jyoti Bhaskar
Ovarian Stimulation in IUI- Overview Sr. Jyoti BhaskarLifecare Centre
 
Letrozole as Ovulation Inducer
Letrozole as Ovulation InducerLetrozole as Ovulation Inducer
Letrozole as Ovulation Inducer
Sujoy Dasgupta
 
Ovulation induction
Ovulation inductionOvulation induction
Ovulation induction
nermine amin
 
Monitoring ART cycle Aboubakr Elnashar
Monitoring ART cycle Aboubakr ElnasharMonitoring ART cycle Aboubakr Elnashar
Monitoring ART cycle Aboubakr Elnashar
Aboubakr Elnashar
 
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Lifecare Centre
 

What's hot (20)

Anti mullerian hormone
Anti mullerian hormoneAnti mullerian hormone
Anti mullerian hormone
 
Poor ovarian Response
Poor ovarian ResponsePoor ovarian Response
Poor ovarian Response
 
Management of poor ovarian reserve- Dr Parul Katiyar
Management of poor ovarian reserve- Dr Parul KatiyarManagement of poor ovarian reserve- Dr Parul Katiyar
Management of poor ovarian reserve- Dr Parul Katiyar
 
Role Of AMH In Infertility , Dr. Sharda Jain , Life Care Centre
Role Of AMH In Infertility , Dr. Sharda Jain , Life Care Centre Role Of AMH In Infertility , Dr. Sharda Jain , Life Care Centre
Role Of AMH In Infertility , Dr. Sharda Jain , Life Care Centre
 
LETROZOLE IN THE MANAGEMENT OF INFERTILITY
 LETROZOLE IN THE MANAGEMENT OF INFERTILITY LETROZOLE IN THE MANAGEMENT OF INFERTILITY
LETROZOLE IN THE MANAGEMENT OF INFERTILITY
 
Reduced ovarian reserve aveya
Reduced ovarian reserve aveyaReduced ovarian reserve aveya
Reduced ovarian reserve aveya
 
OVARIAN RESERVE AND INFERTILITY
OVARIAN RESERVE AND INFERTILITYOVARIAN RESERVE AND INFERTILITY
OVARIAN RESERVE AND INFERTILITY
 
Letrozole in Ovulation Induction
Letrozole in Ovulation InductionLetrozole in Ovulation Induction
Letrozole in Ovulation Induction
 
Ovarian Reserve Testing in Infertility Dr. Jyoti Agarwal Dr. Sharda Jain
Ovarian  Reserve Testing in Infertility Dr. Jyoti Agarwal Dr. Sharda JainOvarian  Reserve Testing in Infertility Dr. Jyoti Agarwal Dr. Sharda Jain
Ovarian Reserve Testing in Infertility Dr. Jyoti Agarwal Dr. Sharda Jain
 
Management of poor ovarian response
Management of poor ovarian responseManagement of poor ovarian response
Management of poor ovarian response
 
Assessment and treatment of people with fertility problem NICE guideline, 2013
Assessment and treatment of people with fertility problemNICE guideline, 2013Assessment and treatment of people with fertility problemNICE guideline, 2013
Assessment and treatment of people with fertility problem NICE guideline, 2013
 
Amh test
Amh testAmh test
Amh test
 
Amh
AmhAmh
Amh
 
Discordance between AMH &FSH
Discordance between AMH &FSHDiscordance between AMH &FSH
Discordance between AMH &FSH
 
Ovulation Induction in PCOS
Ovulation Induction in PCOSOvulation Induction in PCOS
Ovulation Induction in PCOS
 
Ovarian Stimulation in IUI- Overview Sr. Jyoti Bhaskar
Ovarian Stimulation in IUI- Overview Sr. Jyoti BhaskarOvarian Stimulation in IUI- Overview Sr. Jyoti Bhaskar
Ovarian Stimulation in IUI- Overview Sr. Jyoti Bhaskar
 
Letrozole as Ovulation Inducer
Letrozole as Ovulation InducerLetrozole as Ovulation Inducer
Letrozole as Ovulation Inducer
 
Ovulation induction
Ovulation inductionOvulation induction
Ovulation induction
 
Monitoring ART cycle Aboubakr Elnashar
Monitoring ART cycle Aboubakr ElnasharMonitoring ART cycle Aboubakr Elnashar
Monitoring ART cycle Aboubakr Elnashar
 
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
Update on LETROZOLE Current Guidelines for Ovulation Induction Dr. Sharda Jain
 

Similar to RHG Congress 2018 - Richard A Anderson

Optimizing iui results
Optimizing iui resultsOptimizing iui results
Optimizing iui results
vandana bansal
 
Unexplained Infertility - By Dr Dhorepatil Bharati
Unexplained Infertility - By Dr Dhorepatil BharatiUnexplained Infertility - By Dr Dhorepatil Bharati
Unexplained Infertility - By Dr Dhorepatil Bharati
Bharati Dhorepatil
 
Unexplained Infertility - By Dhorepatil Bharati
Unexplained Infertility - By Dhorepatil BharatiUnexplained Infertility - By Dhorepatil Bharati
Unexplained Infertility - By Dhorepatil Bharati
Bharati Dhorepatil
 
ART options for poor responders.pdf
ART options for poor responders.pdfART options for poor responders.pdf
ART options for poor responders.pdf
Marmara University School of Medicine
 
Micronised progesterone in preterm labour
Micronised progesterone in preterm labourMicronised progesterone in preterm labour
Micronised progesterone in preterm labour
Dr Meenakshi Sharma
 
Top Five Problems You Have with Ovulation Induction and How to Solve Them
Top Five Problems You Have with Ovulation Induction and How to Solve ThemTop Five Problems You Have with Ovulation Induction and How to Solve Them
Top Five Problems You Have with Ovulation Induction and How to Solve ThemSandro Esteves
 
Are we giving much importance to AMH in infertility practice?
Are we giving much importance to AMH in infertility practice?Are we giving much importance to AMH in infertility practice?
Are we giving much importance to AMH in infertility practice?
Sujoy Dasgupta
 
Low AMH- Is it linked to Infertility?
Low AMH- Is it linked to Infertility?Low AMH- Is it linked to Infertility?
Low AMH- Is it linked to Infertility?
Sujoy Dasgupta
 
Challenging scenarios in infertility
Challenging scenarios in infertilityChallenging scenarios in infertility
Challenging scenarios in infertility
NARENDRA MALHOTRA
 
The Truth About Ovarian Hyperestimulation Syndrome and How to Avoid It
The Truth About Ovarian Hyperestimulation Syndrome and How to Avoid ItThe Truth About Ovarian Hyperestimulation Syndrome and How to Avoid It
The Truth About Ovarian Hyperestimulation Syndrome and How to Avoid ItSandro Esteves
 
Letrozol & reproduction
Letrozol & reproductionLetrozol & reproduction
Letrozol & reproduction
Hesham Al-Inany
 
Is miscarriage preventable? gynae symposium
Is miscarriage preventable? gynae symposiumIs miscarriage preventable? gynae symposium
Is miscarriage preventable? gynae symposiumobsgynhsnz
 
Infertility.(By Craig)
Infertility.(By Craig)Infertility.(By Craig)
Infertility.(By Craig)drmcbansal
 
ovarian reserve testing final 1.pptx
ovarian reserve testing final 1.pptxovarian reserve testing final 1.pptx
ovarian reserve testing final 1.pptx
DrAsthaGupta1
 
Recurrent pregnancy loss
Recurrent pregnancy loss Recurrent pregnancy loss
Recurrent pregnancy loss
Dr.Laxmi Agrawal Shrikhande
 
Progestogens in miscarriages | Progestogens in Early Pregnancy | Seeds of In...
Progestogens in miscarriages  | Progestogens in Early Pregnancy | Seeds of In...Progestogens in miscarriages  | Progestogens in Early Pregnancy | Seeds of In...
Progestogens in miscarriages | Progestogens in Early Pregnancy | Seeds of In...
SOI Delhi
 
Recurrent miscarriage RCOG, 2011 Up to date, 2013
Recurrent miscarriage RCOG, 2011 Up to date, 2013Recurrent miscarriage RCOG, 2011 Up to date, 2013
Recurrent miscarriage RCOG, 2011 Up to date, 2013
Aboubakr Elnashar
 
Role of IUI in the era of IVF
Role of IUI in the era of IVFRole of IUI in the era of IVF
Role of IUI in the era of IVF
Sujoy Dasgupta
 
ART for women over 40 years of age.pdf
ART for women over  40 years of age.pdfART for women over  40 years of age.pdf
ART for women over 40 years of age.pdf
Marmara University School of Medicine
 

Similar to RHG Congress 2018 - Richard A Anderson (20)

Optimizing iui results
Optimizing iui resultsOptimizing iui results
Optimizing iui results
 
Unexplained Infertility - By Dr Dhorepatil Bharati
Unexplained Infertility - By Dr Dhorepatil BharatiUnexplained Infertility - By Dr Dhorepatil Bharati
Unexplained Infertility - By Dr Dhorepatil Bharati
 
Unexplained Infertility - By Dhorepatil Bharati
Unexplained Infertility - By Dhorepatil BharatiUnexplained Infertility - By Dhorepatil Bharati
Unexplained Infertility - By Dhorepatil Bharati
 
ART options for poor responders.pdf
ART options for poor responders.pdfART options for poor responders.pdf
ART options for poor responders.pdf
 
Micronised progesterone in preterm labour
Micronised progesterone in preterm labourMicronised progesterone in preterm labour
Micronised progesterone in preterm labour
 
Top Five Problems You Have with Ovulation Induction and How to Solve Them
Top Five Problems You Have with Ovulation Induction and How to Solve ThemTop Five Problems You Have with Ovulation Induction and How to Solve Them
Top Five Problems You Have with Ovulation Induction and How to Solve Them
 
Are we giving much importance to AMH in infertility practice?
Are we giving much importance to AMH in infertility practice?Are we giving much importance to AMH in infertility practice?
Are we giving much importance to AMH in infertility practice?
 
Low AMH- Is it linked to Infertility?
Low AMH- Is it linked to Infertility?Low AMH- Is it linked to Infertility?
Low AMH- Is it linked to Infertility?
 
Challenging scenarios in infertility
Challenging scenarios in infertilityChallenging scenarios in infertility
Challenging scenarios in infertility
 
The Truth About Ovarian Hyperestimulation Syndrome and How to Avoid It
The Truth About Ovarian Hyperestimulation Syndrome and How to Avoid ItThe Truth About Ovarian Hyperestimulation Syndrome and How to Avoid It
The Truth About Ovarian Hyperestimulation Syndrome and How to Avoid It
 
Dhea jdr
Dhea jdrDhea jdr
Dhea jdr
 
Letrozol & reproduction
Letrozol & reproductionLetrozol & reproduction
Letrozol & reproduction
 
Is miscarriage preventable? gynae symposium
Is miscarriage preventable? gynae symposiumIs miscarriage preventable? gynae symposium
Is miscarriage preventable? gynae symposium
 
Infertility.(By Craig)
Infertility.(By Craig)Infertility.(By Craig)
Infertility.(By Craig)
 
ovarian reserve testing final 1.pptx
ovarian reserve testing final 1.pptxovarian reserve testing final 1.pptx
ovarian reserve testing final 1.pptx
 
Recurrent pregnancy loss
Recurrent pregnancy loss Recurrent pregnancy loss
Recurrent pregnancy loss
 
Progestogens in miscarriages | Progestogens in Early Pregnancy | Seeds of In...
Progestogens in miscarriages  | Progestogens in Early Pregnancy | Seeds of In...Progestogens in miscarriages  | Progestogens in Early Pregnancy | Seeds of In...
Progestogens in miscarriages | Progestogens in Early Pregnancy | Seeds of In...
 
Recurrent miscarriage RCOG, 2011 Up to date, 2013
Recurrent miscarriage RCOG, 2011 Up to date, 2013Recurrent miscarriage RCOG, 2011 Up to date, 2013
Recurrent miscarriage RCOG, 2011 Up to date, 2013
 
Role of IUI in the era of IVF
Role of IUI in the era of IVFRole of IUI in the era of IVF
Role of IUI in the era of IVF
 
ART for women over 40 years of age.pdf
ART for women over  40 years of age.pdfART for women over  40 years of age.pdf
ART for women over 40 years of age.pdf
 

More from Reproductive Health Group

RHG Congress 2018 - Rachel Cutting
RHG Congress 2018 - Rachel CuttingRHG Congress 2018 - Rachel Cutting
RHG Congress 2018 - Rachel Cutting
Reproductive Health Group
 
RHG Congress 2018 - Cristina Hickman
RHG Congress 2018 - Cristina HickmanRHG Congress 2018 - Cristina Hickman
RHG Congress 2018 - Cristina Hickman
Reproductive Health Group
 
RHG Congress 2018 - Luciano Nardo
RHG Congress 2018 - Luciano NardoRHG Congress 2018 - Luciano Nardo
RHG Congress 2018 - Luciano Nardo
Reproductive Health Group
 
RHG Congress 2018 - Christine Leary
RHG Congress 2018 - Christine LearyRHG Congress 2018 - Christine Leary
RHG Congress 2018 - Christine Leary
Reproductive Health Group
 
RHG Congress 2018 - Andrew Drakeley
RHG Congress 2018 - Andrew DrakeleyRHG Congress 2018 - Andrew Drakeley
RHG Congress 2018 - Andrew Drakeley
Reproductive Health Group
 
RHG Congress 2018 - Alison McTavish
RHG Congress 2018 - Alison McTavishRHG Congress 2018 - Alison McTavish
RHG Congress 2018 - Alison McTavish
Reproductive Health Group
 
RHG Congress 2018 - Elpida Fragouli
RHG Congress 2018 - Elpida FragouliRHG Congress 2018 - Elpida Fragouli
RHG Congress 2018 - Elpida Fragouli
Reproductive Health Group
 
RHG Congress 2018 - Jason Kasraie
RHG Congress 2018 - Jason KasraieRHG Congress 2018 - Jason Kasraie
RHG Congress 2018 - Jason Kasraie
Reproductive Health Group
 
RHG Congress 2018 - Rene Woderich
RHG Congress 2018 - Rene WoderichRHG Congress 2018 - Rene Woderich
RHG Congress 2018 - Rene Woderich
Reproductive Health Group
 
GP Leaflet
GP LeafletGP Leaflet
Infertility for Primary Care - Professor Luciano Nardo
Infertility for Primary Care - Professor Luciano NardoInfertility for Primary Care - Professor Luciano Nardo
Infertility for Primary Care - Professor Luciano Nardo
Reproductive Health Group
 

More from Reproductive Health Group (11)

RHG Congress 2018 - Rachel Cutting
RHG Congress 2018 - Rachel CuttingRHG Congress 2018 - Rachel Cutting
RHG Congress 2018 - Rachel Cutting
 
RHG Congress 2018 - Cristina Hickman
RHG Congress 2018 - Cristina HickmanRHG Congress 2018 - Cristina Hickman
RHG Congress 2018 - Cristina Hickman
 
RHG Congress 2018 - Luciano Nardo
RHG Congress 2018 - Luciano NardoRHG Congress 2018 - Luciano Nardo
RHG Congress 2018 - Luciano Nardo
 
RHG Congress 2018 - Christine Leary
RHG Congress 2018 - Christine LearyRHG Congress 2018 - Christine Leary
RHG Congress 2018 - Christine Leary
 
RHG Congress 2018 - Andrew Drakeley
RHG Congress 2018 - Andrew DrakeleyRHG Congress 2018 - Andrew Drakeley
RHG Congress 2018 - Andrew Drakeley
 
RHG Congress 2018 - Alison McTavish
RHG Congress 2018 - Alison McTavishRHG Congress 2018 - Alison McTavish
RHG Congress 2018 - Alison McTavish
 
RHG Congress 2018 - Elpida Fragouli
RHG Congress 2018 - Elpida FragouliRHG Congress 2018 - Elpida Fragouli
RHG Congress 2018 - Elpida Fragouli
 
RHG Congress 2018 - Jason Kasraie
RHG Congress 2018 - Jason KasraieRHG Congress 2018 - Jason Kasraie
RHG Congress 2018 - Jason Kasraie
 
RHG Congress 2018 - Rene Woderich
RHG Congress 2018 - Rene WoderichRHG Congress 2018 - Rene Woderich
RHG Congress 2018 - Rene Woderich
 
GP Leaflet
GP LeafletGP Leaflet
GP Leaflet
 
Infertility for Primary Care - Professor Luciano Nardo
Infertility for Primary Care - Professor Luciano NardoInfertility for Primary Care - Professor Luciano Nardo
Infertility for Primary Care - Professor Luciano Nardo
 

Recently uploaded

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 

Recently uploaded (20)

ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 

RHG Congress 2018 - Richard A Anderson

  • 1. Clinical significance of diminished ovarian reserve Richard A Anderson Elsie Inglis Professor of Clinical Reproductive Science University of Edinburgh
  • 2. The ‘poor responder’ • What do we mean by this term? • Is it reliable? • What can we do about it? • What might we be able to do about it?
  • 3. Association between egg number and live birth rate Sunkara SK et al. Hum. Reprod. 2011;26:1768-1774 HFEA data: 400,000 cycles
  • 4. The increasing gap between women’s wishes and biology 0 5 10 15 20 25 <29 30-34 35-39 40-44 >45 Live birth rate per ET Templeton et al 1996 Lancet 384; 1402 0 50000 100000 150000 200000 250000 300000 <20 20-24 25-29 30-34 35-39 40-44 45+ 1995 2005 OHE Compendium of Health Statistics
  • 5. The variation as well as decline in follicular endowment Wallace and Kelsey 2010 PLoS One 5; e8772 Non-growing follicle number Age
  • 6. Wallace and Kelsey 2010 PLoS One 5; e8772 200/month 6.7 per day 22/month 2000/month Calculation of rate of follicle activation
  • 7. The long and hazardous road of follicle development From McGee and Hsueh 2000 Endocr Rev 21, 200 ??? 120 Days Primordial Primary Secondary Antral Human (2 - 5mm) Rat (0.2 - 0.4mm) Atretic Pre-ovulatory Follicles OVULATION SELECTION AND DOMINANCE CYCLIC RECRUITMENT INITIAL RECRUITMENT >30 Days 28 Days 2-3 Days 71 Days 14 Days Human Rat Similar durations in Gougeon A 1986 Hum Reprod On the radar
  • 8. AMH and AFC reflect primordial follicle number Hansen et al 2010 Fertil Steril Stereological analysis following oophorectomy, n=42 LogPrimordialfolliclenumber
  • 9. R² = 0.6646 0 1 2 3 4 5 6 7 0 1 2 3 4 5 6 AMH(ng/ml) Log NGF number NGF vs AMH R² = 0.600 1 10 100 20 30 40 50 60NGF/AMH Age NGF/AMH ratio vs age Fewer antral follicles per NGF with age Increased early selection? The changing relationship between primordial follicle number and AMH with age
  • 10. Prediction of poor response AUROC 95% CI Age 0.60 0.57, 0.64 AMH 0.81 0.77, 0.84 Age, FSH 0.69 0.66, 0.72 Age, AFC 0.76 0.72, 0.80 Age, AMH 0.80 0.76, 0.84 Age, AMH, AFC 0.80 0.74, 0.86 Age, AMH, AFC, FSH 0.81 0.75, 0.0.86 IMPORT consortium Hum Repro Update 2013 EXPORT consortium Fertil Steril 2013 Biomarkers predict poor response
  • 11. ‘Bologna’ criteria for poor response • 2 of 3: – Advanced maternal age or other risk factor – Previous POR (≤3 oocytes) – Abnormal ovarian reserve test • Or 2 episodes of POR with max stimulation • Reproducibility in a second cycle: – 64% of ‘unexpected’ will show a normal response – 31% of ‘expected’ will show a normal response (n=225, Klinkert et al 2004) Ferraretti AP et al; ESHRE working group on Poor Ovarian Response Definition 2011
  • 12. 69% of DOR cycles did not result in POR 0 5 10 15 20 2004 2011 DOR live birth POR live birth Devine K et al Fertil Steril 2015, 3, 612 Using ‘Diminished ovarian reserve’ to predict poor ovarian response Diminished ovarian reserve in the United States assisted reproductive technology population: diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System
  • 13. Chai J, Lee VCY, Yeung TWY, Li RWH, Ho PC, et al. (2015) Live Birth and Cumulative Live Birth Rates in Expected Poor Ovarian Responders Defined by the Bologna Criteria Following IVF/ICSI Treatment. PLoS ONE 10(3): e0119149. Expected Normal (562) Expected Poor (160) No of oocytes 11 (8-15) 5 (3-8) Cancellations 0 1 (0.6%) Live birth 202 (35.9%) 38 (23.8%) Fresh plus frozen LBR 323/512 (62.8%) 48/134 (35.8%) How well do predicted poor responders do in IVF/ICSI? 1152 women undergoing first IVF/ICSI cycle (cutoffs: age 40, AFC 6, AMH 2ng/ml)
  • 14. SART data by diagnosis Luke et al 2012 NEJM 366, 2483
  • 15. ROC analysis for AMH and successful egg retrieval in DOR patients (FSH>10IU/L) Burks HR et al Fertil Sertil 2015, 3, 643 Can we do better? Ultrasensitive AMH assay No egg retrievals at <100pg/ml n=24 /group
  • 16. What else does having a poor ovarian reserve mean? From McGee and Hsueh 2000 Endocr Rev 21, 200 ??? 120 Days Primordial Primary Secondary Antral Human (2 - 5mm) Rat (0.2 - 0.4mm) Atretic Pre-ovulatory Follicles OVULATION SELECTION AND DOMINANCE CYCLIC RECRUITMENT INITIAL RECRUITMENT >30 Days 28 Days 2-3 Days 71 Days 14 Days Human Rat
  • 17. Sowers, M. R. et al. J Clin Endocrinol Metab 2008;93:3478-3483 Prediction of menopause 50 women followed prospectively (Michigan Bone Health and Metabolism Study) 6 annual assessments Mean initial age 42 yr AMH signif related to both time to and age at FMP Inhibin B less predictive of both
  • 18. AMH and prediction of menopause Broer SL et al 2011 JCE&M 257 ovulatory women, 21-46yr Reassessed after 11 years (19% menopausal) AMH at baseline Menopause by AMH centileLow age specific AMH Shift towards younger age at menopause High age specific AMH Shift towards higher age at menopause
  • 19. AMH and prediction of menopause Tehrani et al 2013 JCE&M 98, 729
  • 20. 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0 1 2 3 4 5 6 Cumulativeproportionofwomen achievingpregnancy Time from cessation of birth control (cycles) 0 10 20 30 40 50 60 70 19 21 23 25 27 29 31 33 35 AMH(pmol/L) Age (years) AMH and fecundability Hagen et al 2012 Fertil Steril AMH quintiles, middle 3 combined
  • 21. 981 women aged 30 to 44, trying to conceived max 3 months at study entry Steiner AZ et al, 2017, JAMA Adjusted for age, smoking, contraception, BMI, race, prev pregnancy
  • 22. Changes in ovarian reserve after chemotherapy Identification of post- cancer compromised ovarian reserve? Ovarianreserve
  • 23. Effects of A(B)VD and BEACOPP on ovarian function in Hodgkin lymphoma 0 5 10 15 20 Pre chemo 2 cycles EOT 1 2 3 AMH(pmol/L) AMH Blue: ABVD Red: BEACOPP (after 2 cycles of ABVD) Years after chemotherapy Chemotherapy Anderson RA et al 2018 Lancet Oncol
  • 24. AMH and pregnancy after HL 0 2 4 6 8 10 12 Pre chemo 2 cycles EOT 1 2 3 AMH(pmol/l) During pregnancy
  • 25. Pre C ycle 1 C ycle 2 C ycle 3 C ycle 4 C ycle 5 C ycle 6 0.0 0.5 1.0 1.5 2.0 2.5 ** ** *** *** AMH(ng/ml) AMH: application in childhood cancer Pre End Recovery 0 1 2 3 * ** AMH(ng/ml) High risk Pre End Recovery 0 1 2 3 ** AMH(ng/ml) Medium/low risk 22 girls age 0.3-15yr 17 prepubertal Brougham et al 2012 JCE&M 97, 2059
  • 26. AMH in 3 girls with cancer 0 50 100 150 200 0.0 1.0 2.0 3.0 Age 2.4; rhabdomyosarcoma 0 25 50 75 0.0 0.2 0.4 0.6 0.8 1.0 Weeks AMH(ng/ml) Age 1.2; neuroblastoma 0 50 100 150 0.0 0.5 1.0 1.5 2.0 Weeks Age 14.6: Hodgkin’s lymphoma Brougham et al 2012 JCE&M 97, 2059 Can this predict their reproductive lifespan?
  • 27. Age and miscarriage Maternal age Percentmiscarrying Nyboe Andersen et al 2000 BMJ 320, 1708
  • 28. AMH and miscarriage after IVF? Tarasconi et al Fertil Steril 2017, 108, 518 Age but not AMH predicted clinical pregnancy and live birth
  • 29. AMH and miscarriage in natural pregnancy? Schumacker et al 2018 Fertil Steril 109, 1065Women (n = 533), age 30 - 44 Women with severely diminished ovarian reserve (AMH < 0.4 ng/mL) miscarried at over twice the rate of women with an AMH > 1 ng/mL (HR 2.3; 1.3-4.3).
  • 30. AMH and miscarriage in natural pregnancy? multivariable Cox model adjusting for maternal age, race, obesity, and recurrent pregnancy loss suggested that risk of miscarriage showed a nonsignificant trend to decrease with increasing AMH (HR per unit increase in natural log of AMH = 0.85; 0.72-1.01). Schumacker et al 2018 Fertil Steril 109, 1065
  • 31. Can we intervene to promote follicle development? From McGee and Hsueh 2000 Endocr Rev 21, 200 ??? 120 Days Primordial Primary Secondary Antral Human (2 - 5mm) Rat (0.2 - 0.4mm) Atretic Pre-ovulatory Follicles OVULATION SELECTION AND DOMINANCE CYCLIC RECRUITMENT INITIAL RECRUITMENT >30 Days 28 Days 2-3 Days 71 Days 14 Days Human Rat
  • 32. Local and gonadotrophic regulation of follicle growth Scaramuzzi R et al 1993 Reprod Fertil Develop 5: 459-478 Local FSH
  • 33. Does giving more FSH help? N=501 Standard 150 IU 225 or 450 IU Oocytes retrieved 6.5 7.6 Cancelled first cycle 21% 7% LBR first cycle 18% 18% Cumulative LBR 44.8% 42.4% van Tilborg et al 2017 Hum Reprod 32, 2496 OPTIMIST trial: predicted poor responders (AFC ≤7, 8-10) Outcome: ongoing pregnancy/LB within 18 months
  • 34. RECOMMENDATIONS In patients who are classified as poor responders and pursuing IVF, strong consideration should be given to a mild ovarian- stimulation protocol (low-dose gonadotropins [≤150IU/d] with or without oral agents) due to lower costs and comparable low pregnancy rates compared with traditional IVF stimulation protocols.
  • 35. Adding growth hormone? N=130 rGH +FSH FSH only LBR 11% 14% Hart RJ et al Curr Opin Obstet Gynecol 2017 LIGHT study rGH group had more egg recoveries and 1 day less ovarian stimulation Recruitment stopped early a benefit for the use of the adjunct GH, with a reduction in the duration of ovarian stimulation required for oocyte retrieval, the collection of a greater number of oocytes than placebo, and an improvement in many of the early clinical parameters; however, there was no evidence of an increased chance of a live birth for the use of GH
  • 36. Local and gonadotrophic regulation of follicle growth Scaramuzzi R et al 1993 Reprod Fertil Develop 5: 459-478 Local Gns
  • 37. By size Vendola KA et al 1998 J Clin Invest 12, 2622 Androgens stimulate early follicular growth in the primate Rhesus monkey Treated with T or DHT
  • 38. DHEA pretreatment and LBR/ongoing pregnancy Nagels HE et al Cochrane Database Syst Rev. 2015:CD009749 OR 1.81, 95% CI 1.25 to 2.62 (8 RCTs, N = 878)
  • 39. Testosterone pretreatment and LBR/ongoing pregnancy Nagels HE et al Cochrane Database Syst Rev. 2015:CD009749 OR 2.60, 95% CI 1.30 to 5.20 (four RCTs, N = 345)
  • 40. Novel loci to impact follicle development From McGee and Hsueh 2000 Endocr Rev 21, 200 ??? 120 Days Primordial Primary Secondary Antral Human (2 - 5mm) Rat (0.2 - 0.4mm) Atretic Pre-ovulatory Follicles OVULATION SELECTION AND DOMINANCE CYCLIC RECRUITMENT INITIAL RECRUITMENT >30 Days 28 Days 2-3 Days 71 Days 14 Days Human Rat AMH Regulation of growth activation  sensitivity to FSH/selection
  • 41. Campbell BK et al. Endocrinology 2012;153:4533-4543 Immunisation against AMH promotes follicle progression in sheep Intraovarian AMH antibody increases the number of antral follicles at midcycle and primates Xu J et al. Hum. Reprod. 2016;31:1522-1530 Control +AMH antibody
  • 42. Conclusions • Diminished ovarian reserve is common but we aren’t very good at predicting poor response • But still has acceptable outcomes in younger women • Can we improve response and outcomes? – Yes, but effect size and safety/risks unclear – Improved understanding of ovarian function will allow new developments